Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Beclometasone vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Clinical response at 8 weeks · Patients with active or quiescent lymphocytic colitis

Beclometasone dipropionate showed no clear difference in clinical response at 8 weeks compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating lymphocytic colitis 2017 · Cochrane Headline outcomes only
RR 0.97 [0.75, 1.24]
1 study · 46 participants
Low

Beclometasone vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Maintenance of clinical response · Patients with active or quiescent lymphocytic colitis

It is very uncertain whether beclometasone dipropionate changes maintenance of clinical response at 12 weeks compared with mesalazine (very low certainty).

1 finding from 1 review

Interventions for treating lymphocytic colitis 2017 · Cochrane Headline outcomes only
RR 1.29 [0.4, 4.18]
1 study · 46 participants
Very low

Beclometasone dipropionate (systemic corticosteroid) vs Placebo or no treatment

Outcome not reported · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and clinical examination;…

The review found no eligible studies for this question.

1 finding from 1 review

Systemic interventions for recurrent aphthous stomatitis (mouth ulcers) 2012 · Cochrane All outcomes
Table 1: 'Studies of these corticosteroids were not found or included in the review but are included here for completeness.' No trial of beclometasone dipropionate for RAS was identified.
0 studies
No studies found